Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19,763 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized Clinical Trial of Extending the Time Window of Endovascular Therapy in the Triage of Late Presenting Stroke Beyond 24 h (SKIP-EXTEND): Rationale and Study Protocol.
Suzuki K, Matsumaru Y, Takeuchi M, Morimoto M, Kaneko J, Shigeta K, Takigawa T, Katano T, Aoki J, Hayakawa M, Otsuka T, Fujimoto S, Iihara K, Kimura K; SKIP-EXTEND Trial Investigators. Suzuki K, et al. Neurol Med Chir (Tokyo). 2025 Jan 24. doi: 10.2176/jns-nmc.2024-0196. Online ahead of print. Neurol Med Chir (Tokyo). 2025. PMID: 39864837
Letermovir-inclusive combination therapy for a refractory and resistant infection by cytomegalovirus with UL54 mutation following a hematopoietic stem cell transplant for MHC Class II deficiency.
Ashaari Muhamad ND, Kanie N, Otsubo Y, Suzuki K, Kinoshita K, Horikoshi Y. Ashaari Muhamad ND, et al. Among authors: suzuki k. J Infect Chemother. 2025 Jan 23:102627. doi: 10.1016/j.jiac.2025.102627. Online ahead of print. J Infect Chemother. 2025. PMID: 39863069
19,763 results
You have reached the last available page of results. Please see the User Guide for more information.